CD274 and neoplasm: While delivering tumor-specific antigens, the OMVs activated co-stimulatory second signals in APCs, and the anti-PD-L1 antibodies effectively blocked inhibitory PD-L1 signaling within the tumor, thereby enabling robust activation of tumor-specific immune responses (Lu et al., 2025).